USA - NASDAQ:PIRS - US7207952026 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to PIRS. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for PIERIS PHARMACEUTICALS INC (PIRS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering PIERIS PHARMACEUTICALS INC (PIRS) is 6.